لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Chaplin Jay, Chung-leung Chan, Vijetha Kumar, Shangjin Li, Allie Roach, Ayesha Misquith, Sowbarnika S. Ratliff, Michael Wijaranakula, Matthias von Herrath, Jaimie Granger, Ken Coppieters, Justen Cracraft, Philippe P. Pagni, Conor O’Brien, Nikole Perdue, Johnna D. Wesley

المصدر: Diabetes

مصطلحات موضوعية: Autoimmune disease, Type 1 diabetes, business.industry, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Interleukin, Immunosuppression, Immunotherapy, medicine.disease, Pharmacology and Therapeutics, Cytokine, Immune system, Diabetes mellitus, Immunology, Internal Medicine, medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01a535debeb8f82479f4ee151ee1ff3
https://pubmed.ncbi.nlm.nih.gov/34389610

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pagni PP; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Chaplin J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Wijaranakula M; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Wesley JD; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Granger J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Cracraft J; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., O'Brien C; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Perdue N; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Kumar V; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Li S; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Ratliff SS; La Jolla Institute for Immunology, La Jolla, CA, USA., Roach A; Type 1 Diabetes & Kidney Disease, Global Drug Discovery, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Misquith A; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Chan CL; Discovery Biologics, Global Research Technologies, Novo Nordisk Research Center Seattle, Inc., Seattle, WA, U.S.A., Coppieters K; Project and Alliance Management, Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark., von Herrath M; La Jolla Institute for Immunology, La Jolla, CA, USA.; Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark.

المصدر: Diabetes [Diabetes] 2021 Aug 13. Date of Electronic Publication: 2021 Aug 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE